- Home
- MDXH vs QSI Comparison
MDXH vs QSI Comparison
Compare MDXH & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXH
- QSI
- Stock Information
- Founded
- MDXH 2003
- QSI 2013
- Country
- MDXH Belgium
- QSI United States
- Employees
- MDXH N/A
- QSI N/A
- Industry
- MDXH
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- MDXH
- QSI Health Care
- Exchange
- MDXH Nasdaq
- QSI Nasdaq
- Market Cap
- MDXH 203.4M
- QSI 226.8M
- IPO Year
- MDXH 2021
- QSI N/A
- Fundamental
- Price
- MDXH $4.92
- QSI $2.15
- Analyst Decision
- MDXH Buy
- QSI Strong Buy
- Analyst Count
- MDXH 1
- QSI 3
- Target Price
- MDXH $6.00
- QSI $2.88
- AVG Volume (30 Days)
- MDXH 274.6K
- QSI 18.7M
- Earning Date
- MDXH 11-12-2025
- QSI 11-05-2025
- Dividend Yield
- MDXH N/A
- QSI N/A
- EPS Growth
- MDXH N/A
- QSI N/A
- EPS
- MDXH N/A
- QSI N/A
- Revenue
- MDXH $98,953,000.00
- QSI $3,412,000.00
- Revenue This Year
- MDXH $24.43
- QSI N/A
- Revenue Next Year
- MDXH $21.00
- QSI $219.33
- P/E Ratio
- MDXH N/A
- QSI N/A
- Revenue Growth
- MDXH 22.56
- QSI 100.47
- 52 Week Low
- MDXH $1.35
- QSI $0.61
- 52 Week High
- MDXH $5.33
- QSI $5.77
- Technical
- Relative Strength Index (RSI)
- MDXH 64.64
- QSI 54.47
- Support Level
- MDXH $4.71
- QSI $2.02
- Resistance Level
- MDXH $5.33
- QSI $2.44
- Average True Range (ATR)
- MDXH 0.30
- QSI 0.26
- MACD
- MDXH 0.05
- QSI -0.05
- Stochastic Oscillator
- MDXH 72.11
- QSI 16.67
About MDXH MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.